Genprex
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3300 Bee Caves Rd Ste 650-227, West Lake...Phone Number
(877) 774-4679Website
www.genprex.comRevenue
-Stock Symbol
GNPXIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Genprex
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel trea...Explore more
Genprex Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Genprex your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Genprex had a recent Job posting/layoffs
Product Launch: Get notified when Genprex launches new products
Genprex, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Genprex is spiking on competitors!
Earning: See what the market has to say on Genprex recently announced quarterly report
Check if Genprex has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Genprex has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Genprex
Recommended Actions
Find VP level buyers at Genprex
Find more new buyers
Compare Similar Companies to Genprex
Compare insights from companies similar to Genprex, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Genprex is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Genprex is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Genprex.
Genprex financials insights
Gather financial insights about Genprex, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Stock Offering
$25.5M
2023
Share Placement
$7.5M
Genprex Tech Stack
A closer look at the technologies used by Genprex
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Product Development, Product Management, Intellectual Property, Legal Affairs, Pharmaceuticals
Project
Product Development, Product Management, Intellectual Property, Legal Affairs, Pharmaceuticals
Partnership
Project
Partnership, Product Development, Product Management, Intellectual Property, Legal Affairs, Medical Research, Pharmaceuticals, Clinical Operations
Earnings
Manufacturing Operations, Operations
Genprex News & Media
Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies
Collaboration Advances Biomarker-Driven Patient Selection and Precision Medicine in Oncology Validation Studies Aim to Optimize Clinical Trial Patient Selection Criteria AUSTIN, Texas, Aug. 3, 2026 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage...Genprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent Claiming the Combination of Reqorsa® Gene Therapy with Either PD-1 or PD-L1 Antibodies to Treat Cancer
Patent Covers Acclaim-3 Clinical Trials Combining REQORSA Gene Therapy with Genentech, Inc.'s Tecentriq® AUSTIN, Texas, June 22, 2026 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing...Genprex to Participate at BIO International Convention 2026
The BIO International Convention Brings Together More Than 20,000 Biotech Industry Leaders From Around The World AUSTIN, Texas, June 17, 2026 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing...Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting
Trop-2 H-scores Above 100 and PTEN H-scores Below 100 Correlated With Longer Progression Free Survival in Non-Small Cell Lung Cancer Patients Identified Biomarkers May Predict Patient Response, Enable Targeted Patient Selection and Allow for Precision Medicine AUSTIN, Texas, May 26, 2026...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Genprex
Sign Up For FreeTo access detailed company insights
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex wor... Read More
